Observational study on newly diagnosed axial spondyloarthritis in the UK

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The British Axial Spondyloarthritis Inception Cohort (BAxSIC) aims to gather real-world data on the impact of delayed diagnosis of axial spondyloarthritis (axSpA) on work participation and functional outcomes. This prospective cohort study will enroll patients who have been newly diagnosed with axSpA and are naïve to biologic therapy, assessing various factors such as disease activity, pain, fatigue, and comorbidities over an initial three-year period. The study is conducted in collaboration with the British Society for Spondyloarthritis and the National Axial Spondyloarthritis Society, focusing on patients attending rheumatology clinics in the UK.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Aged ≥16 years.
2. A physician diagnosis of axSpA (including ankylosing spondylitis) within the last 6 months prior to baseline.
3. Willing and able to give informed consent to participate in the study.

Exclusion Criteria:

1. Age \<16 years.
2. Unable to communicate in English or are deemed, in any other way, to be unable to give informed consent

Where it's running

• Chapel Allerton Hospital
  Leeds, United Kingdom Recruiting

Study contacts

• Principal investigator: Helena Marzo-Ortega, MD/PhD — Leeds Teaching Hospital Trust
• Study coordinator: Helena Marzo-Ortega, MD/PhD
• Email: h.marzo-ortega@leeds.ac.uk
• Phone: +44 113 3924848

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Surface topography and spine damage in radiographic axial spondyloarthritis

  This study tests whether a radiation-free 3D surface topography method can reflect spine damage and sagittal balance in adults with radiographic axial spondyloarthritis.

  Recruiting Ankara Etlik City Hospital · Ankara, Yenimahalle · NCT07855393

• RENEW: a digital program to help people with axial spondyloarthritis manage energy and symptoms

  A web-based, peer-led program called RENEW is tested to see if people with axial spondyloarthritis can easily use it, like it, and benefit from it in managing fatigue and symptoms.

  Recruiting University of Michigan · Ann Arbor, Michigan · NCT07836374

• ExerciseRx app for people with axial spondyloarthritis

  A mobile app called ExerciseRx is tested to see if it helps people with axial spondyloarthritis exercise more regularly and feel better than usual care.

  Recruiting at 2 sites University of Washington · Seattle, Washington and 1 other locations · NCT07642622

• Carotid ultrasound to guide prevention of heart disease in inflammatory rheumatic diseases

  In people with inflammatory rheumatic diseases like RA, PsA, AxSpA, or SLE who are at modest cardiovascular risk, a carotid ultrasound test is used to see if they should start stronger lipid-lowering therapy to prevent heart problems.

  Recruiting at 7 sites Phase 4 Instituto de Investigación Marqués de Valdecilla · Alicante, Alicante and 16 other locations · NCT07611747

• Bimekizumab by IV infusion versus subcutaneous injection for adults with psoriatic arthritis or axial spondyloarthritis

  This trial tests whether bimekizumab given by intravenous (IV) infusion behaves the same in the body as the usual subcutaneous injection in adults with psoriatic arthritis or axial spondyloarthritis.

  Recruiting at 65 sites Phase 1 UCB Pharma · Peoria, Arizona and 64 other locations · NCT07290036

• Butantan live tetravalent dengue vaccine for people with autoimmune rheumatic diseases

  This study will test whether a single dose of the Butantan live tetravalent dengue vaccine is safe and produces immune responses in clinically stable people aged 12–59 with autoimmune rheumatic diseases compared with matched healthy volunteers.

  Recruiting at 2 sites Phase 4 University of Sao Paulo General Hospital · São Paulo, São Paulo and 1 other locations · NCT07087912

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.